Please Wait...

Bioclinica Introduces Oncology Rescue Studies Team

Dedicated specialists focus on at-risk trials, driving toward new Oncology therapies

June 2, 2017

Bioclinica®, the worldwide leader in science-enabled medical imaging and core lab service supporting clinical development, today announces the formation of a dedicated team focused on Oncology rescue studies. The team comprises specialists with scientific, medical, Oncology and related domain expertise, as well as senior project managers and operational leads experienced in Oncology rescue studies.

"Due to their large-scale, global nature, Oncology trials tend to be difficult to manage," said Bioclinica's Medical Imaging & Biomarkers Chief Operating Officer Andrew Kraus. Compounding this, differences in type, location and progression of tumors require complex assessment criteria. "To combat these challenges and to address critical worldwide logistics needed for success, Bioclinica partners with sponsors to remove roadblocks to new Oncology therapies."

Bioclinica has more than 1,100 Oncology trials in its portfolio, including 64 U.S. FDA-approved Oncology therapies. The team has provided imaging core lab, expert independent review and supporting scientific services to sponsors from top tier pharmaceutical to smaller companies since 1990. Today Bioclinica is the leading imaging provider in the life sciences industry, offering comprehensive support in all trial phases for all major indications.

In recent years Bioclinica has been tapped to correct a variety of problems in Oncology studies including data loss from scans unable to be analyzed due to lax imaging quality standards on the part of inexperienced providers and those for whom imaging is not a core service. "It's something we avoid in our own studies by having stringent quality control and imaging standards to ensure data across all imaging modalities are acquired in accordance with the protocol and consistent across all time points, subjects and sites," Kraus explained. Aside from its imaging expertise, Bioclinica systems, infrastructure and proactive site management approach are credited by Kraus as key to obtaining the best quality imaging scans possible.

Bioclinica has successfully recovered 14 trials in just the past three years. In one study the sponsor was nearing database lock when they discovered their imaging provider was unable to deliver readings in time. Bioclinica helped the sponsor get out of an urgent situation so they could make their regulatory submission. Other issues such as variability in analysis can be avoided by having standardized imaging in place across all subjects and qualified, experienced reader management.

As imaging is a core specialty of Bioclinica, it has scale and dedicated, in-house readers — the most experienced in the industry. Medical Imaging has approximately 600 employees across its global and growing organization with a staff that includes radiologists, oncologists, data managers, technologists and project managers. The team has unmatched regulatory experience, medical leadership, operational excellence, and a large global workforce to meet the most challenging demands of today's Oncology trials.

"Our team understands the crucial operational aspects and what it takes to run a successful Oncology trial," Kraus commented. He added, "When Bioclinica steps into recovery mode, we do so with three decades of experience and a proven Rescue Study Plan of Action behind us. We work in close partnership with the sponsor to steer troubled studies back on course, paving the way to new Oncology therapies."

Industry professionals can meet with members of Bioclinica's Oncology rescue team at ASCO in booth 13099 through June 5 where Bioclinica is exhibiting and showcasing its Imaging Oncology services. Learn more about Bioclinica's Medical Imaging & Biomarkers business segment online, in the Bioclinica blog and on Bioclinica LinkedIn and Twitter channels.

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

On the hunt for agile IRT? Ask these 5 Qs to see if it's the real thing. DISCLOSURE: We happen to have such an offe… https://t.co/S6507WxBC8
bioclinica (Yesterday)
Be among the 1st to hear findings presented in 6 scientific posters in which experts @bioclinica in #Alzheimers… https://t.co/4mBEtFiX0a
bioclinica (3 days ago)
Still using manual methods for trial budget management and forecasting ? A Bioclinica whitepaper shows how purpose-… https://t.co/WlrHLk9B0z
bioclinica (4 days ago)
Swing by @Bioclinica to discuss global site network partnering opportunities during @MySCRS Asia-Pac Site Solutions… https://t.co/m8GHxSmPMY
bioclinica (5 days ago)
Hello from Clinical Operations in Oncology Trials East Coast where Bioclinica is exhibiting & presenting a case stu… https://t.co/oTKJAVddH4
bioclinica (2 weeks ago)
Challenge overcome! Course-correct a clinical trial & collect 400 time points from 40 sites across the US & EU -- a… https://t.co/n3TLrjW3xi
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen